Research, development and innovation

Carrying out research and development in microbiological safety, best clinical use of blood and development of novel cellular therapeutics.

The Scottish National Blood Transfusion Service (SNBTS) undertakes a portfolio of research and development projects designed to support the strategic and operational priorities of the organisation. 


The Research, Development and Innovation department works in collaboration with Universities, other UK Blood Services and the wider NHSScotland and scientific research communities to ensure relevant and efficient use of research resources.


SNBTS carries out research and development in microbiological surveillance and safety, best clinical use of blood and blood components and the development of novel cellular therapeutics.

The research, development and innovation vision for 2020/21 is to be a centre of research excellence in blood, tissues and cells of European significance, developing and delivering products that have a direct positive impact on patient care.

Tissue and cellular therapy

Research and development of cellular therapeutics and regenerative medicines in alignment with the Scottish Government’s Life Sciences strategy.

Microbiology and components

Maintaining a high level of microbiological safety. Improving effectiveness of blood and tissue products through developing new screening technologies. Improving formulation of blood components.

Clinical transfusion

Improving the efficacy and safety of blood transfusion. Carrying out research into the clinical effects of blood component transfusion in patients.

More information on this service contact research, development and innovation.

Email the research, development and innovation team (external link)